We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
J. Jill
JILL
$336M
| – | – |
-56,856
| Closed | -$652K | – |
|
3427
JPMorgan US Momentum Factor ETF
JMOM
$2.64B
| – | – |
-6,129
| Closed | -$416K | – |
|
3428
PUT
Johnson & Johnson
JNJ
$635B
| – | – |
-100
| Closed | -$24.4K | – |
|
3429
Jasper Therapeutics
JSPR
$17M
| – | – |
-45,656
| Closed | -$40.2K | – |
|
3430
DELISTED
KalVista Pharmaceuticals
KALV
| – | – |
-162,908
| Closed | -$3.28M | – |
|
3431
Openlane
OPLN
$4.6B
| – | – |
-10,800
| Closed | -$315K | – |
|
3432
Kingsoft Cloud Holdings
KC
$2.54B
| – | – |
-136,226
| Closed | -$1.82M | – |
|
3433
Kelly Services Class A
KELYA
$583M
| – | – |
-109,810
| Closed | -$972K | – |
|
3434
KraneShares MSCI Emerging Markets Ex China Index ETF
KEMX
$125M
| – | – |
-4,944
| Closed | -$200K | – |
|
3435
Kinross Gold
KGC
$26.5B
| – | – |
-396,364
| Closed | -$12.1M | – |
|
3436
Kimco Realty
KIM
$15.8B
| – | – |
-59,846
| Closed | -$1.34M | – |
|
3437
Kaltura
KLTR
$220M
| – | – |
-43,124
| Closed | -$52.6K | – |
|
3438
Kimberly-Clark
KMB
$36.6B
| – | – |
-1,182,430
| Closed | -$114M | – |
|
3439
Kemper
KMPR
$1.7B
| – | – |
-168,727
| Closed | -$5.16M | – |
|
3440
CarMax
KMX
$7.32B
| – | – |
-319,573
| Closed | -$13.3M | – |
|
3441
Knowles
KN
$2.75B
| – | – |
-141,574
| Closed | -$3.64M | – |
|
3442
Knife River
KNF
$3.02B
| – | – |
-5,585
| Closed | -$456K | – |
|
3443
Kiniksa Pharmaceuticals
KNSA
$5.99B
| – | – |
-305,371
| Closed | -$14.7M | – |
|
3444
USBC Inc
USBC
$170M
| – | – |
-165,939
| Closed | -$64.7K | – |
|
3445
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$3.55B
| – | – |
-500,000
| Closed | -$32.6M | – |
|
3446
KKR Real Estate Finance Trust
KREF
$337M
| – | – |
-170,695
| Closed | -$1.04M | – |
|
3447
Krystal Biotech
KRYS
$9.22B
| – | – |
-68,343
| Closed | -$17.7M | – |
|
3448
KT
KT
$8.2B
| – | – |
-28,576
| Closed | -$613K | – |
|
3449
KVH Industries
KVHI
$124M
| – | – |
-138,267
| Closed | -$1.24M | – |
|
3450
Quaker Houghton
KWR
$2.68B
| – | – |
-8,513
| Closed | -$1.06M | – |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.